Correlation Between Sonnet Biotherapeutics and Therasense

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Therasense at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Therasense into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Therasense, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Therasense and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Therasense. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Therasense.

Diversification Opportunities for Sonnet Biotherapeutics and Therasense

0.0

Correlation Coefficient

Sonnet Biotherapeutics  Therasense

Pay attention - limited upside

The 3 months correlation between Sonnet and Therasense is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Therasense in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Therasense and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Therasense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Therasense has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Therasense go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Therasense

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Therasense. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 1.63 times less risky than Therasense. The stock trades about -0.21 of its potential returns per unit of risk. The Therasense is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Therasense on September 13, 2024 and sell it today you would lose (0.01) from holding Therasense or give up 100.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Therasense

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Therasense

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Therasense has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Sonnet Biotherapeutics and Therasense

The main advantage of trading using opposite Sonnet Biotherapeutics and Therasense positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Therasense can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Therasense will offset losses from the drop in Therasense's long position.

The idea behind Sonnet Biotherapeutics Holdings and Therasense pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.